Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study: reply

被引:4
作者
Tagami, T. [1 ,2 ]
Matsui, H. [1 ]
Yasunaga, H. [1 ]
机构
[1] Univ Tokyo, Grad Sch Med, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Tokyo 1138555, Japan
[2] Nippon Med Sch, Dept Emergency & Crit Care Med, Tokyo 113, Japan
关键词
HIGH-DOSE ANTITHROMBIN; GUIDELINES; DIAGNOSIS; TRIAL;
D O I
10.1111/jth.12821
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:680 / 682
页数:3
相关论文
共 13 条
[1]   Antithrombin III in critically ill patients: systematic review with meta-analysis and trial sequential analysis [J].
Afshari, Arash ;
Wetterslev, Jorn ;
Brok, Jesper ;
Moller, Ann .
BMJ-BRITISH MEDICAL JOURNAL, 2007, 335 (7632) :1248-1251
[2]  
DELLINGER RP, 2013, INTENS CARE MED, V39, P165, DOI DOI 10.1007/s00134-012-2769-8
[3]   Diagnosis and treatment of disseminated intravascular coagulation: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET) [J].
Di Nisio, Marcello ;
Baudo, Francesco ;
Cosmi, Benilde ;
D'Angelo, Armando ;
De Gasperi, Andrea ;
Malato, Alessandra ;
Schiavoni, Mario ;
Squizzato, Alessandro .
THROMBOSIS RESEARCH, 2012, 129 (05) :E177-E184
[4]   Early Administration of High-Dose Antithrombin in Severe Sepsis: Single Center Results from the KyberSept-Trial [J].
Eid, Alain ;
Wiedermann, Christian J. ;
Kinasewitz, Gary T. .
ANESTHESIA AND ANALGESIA, 2008, 107 (05) :1633-1638
[5]   A randomized, controlled, multicenter trial of the effects of antithrombin on disseminated intravascular coagulation in patients with sepsis [J].
Gando, Satoshi ;
Saitoh, Daizoh ;
Ishikura, Hiroyasu ;
Ueyama, Masashi ;
Otomo, Yasuhiro ;
Oda, Shigeto ;
Kushimoto, Shigeki ;
Tanjoh, Katsuhisa ;
Mayumi, Toshihiko ;
Ikeda, Toshiaki ;
Iba, Toshiaki ;
Eguchi, Yutaka ;
Okamoto, Kohji ;
Ogura, Hiroshi ;
Koseki, Kazuhide ;
Sakamoto, Yuichiro ;
Takayama, Yasuhiro ;
Shirai, Kunihiro ;
Takasu, Osamu ;
Inoue, Yoshiaki ;
Mashiko, Kunihiro ;
Tsubota, Takaya ;
Endo, Shigeatsu .
CRITICAL CARE, 2013, 17 (06)
[6]   Anticoagulant therapy for sepsis-associated disseminated intravascular coagulation: the view from Japan [J].
Iba, T. ;
Gando, S. ;
Thachil, J. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 (07) :1010-1019
[7]   Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation [J].
Kienast, J ;
Juers, M ;
Wiedermann, CJ ;
Hoffmann, JN ;
Ostermann, H ;
Strauss, R ;
Keinecke, HO ;
Warren, BL ;
Opal, SM .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (01) :90-97
[8]  
Levi M, 2009, BRIT J HAEMATOL, V145, P24, DOI [10.1111/j.1365-2141.2008.07445.x, 10.1111/j.1365-2141.2009.07600.x]
[9]   Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study [J].
Tagami, T. ;
Matsui, H. ;
Horiguchi, H. ;
Fushimi, K. ;
Yasunaga, H. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 (09) :1470-1479
[10]   Expert consensus for the treatment of disseminated intravascular coagulation in Japan [J].
Wada, Hideo ;
Asakura, Hidesaku ;
Okamoto, Kohji ;
Iba, Toshiaki ;
Uchiyama, Toshimasa ;
Kawasugi, Kazuo ;
Koga, Shin ;
Mayumi, Toshihiko ;
Koike, Kaoru ;
Gando, Satoshi ;
Kushimoto, Shigeki ;
Seki, Yoshinobu ;
Madoiwa, Seiji ;
Maruyama, Ikuro ;
Yoshioka, Akira .
THROMBOSIS RESEARCH, 2010, 125 (01) :6-11